Insider Trading Alert - LPI, GMCR, VAR, JLL And HAR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 26, 2013, 184 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $199.71 to $214,535,257.08.

Highlighted Stocks Traded by Insiders:

Laredo Petroleum Holdings (LPI) - FREE Research Report

Schuyler Jerry R who is Senior Advisor at Laredo Petroleum Holdings sold 30,444 shares at $29.06 on Nov. 26, 2013. Following this transaction, the Senior Advisor owned 270,027 shares meaning that the stake was reduced by 10.13% with the 30,444 share transaction.

The shares most recently traded at $27.15, down $1.91, or 7.03% since the insider transaction. Historical insider transactions for Laredo Petroleum Holdings go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 85,000
  • 24-Week # shares sold: 137,000

The average volume for Laredo Petroleum Holdings has been 1.4 million shares per day over the past 30 days. Laredo Petroleum Holdings has a market cap of $4.1 billion and is part of the basic materials sector and energy industry. Shares are up 59.69% year to date as of the close of trading on Tuesday.

Laredo Petroleum Holdings, Inc., an independent energy company, focuses on the acquisition, exploration, development, and production of oil and natural gas primarily in the Permian and Mid-Continent regions of the United States. The company has a P/E ratio of 62.7. Currently there are 8 analysts that rate Laredo Petroleum Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LPI - FREE

TheStreet Quant Ratings rates Laredo Petroleum Holdings as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and good cash flow from operations. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Laredo Petroleum Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Green Mountain Coffee Roasters (GMCR) - FREE Research Report

Mackay A D David who is Director at Green Mountain Coffee Roasters bought 10,000 shares at $69.51 on Nov. 26, 2013. Following this transaction, the Director owned 26,135 shares meaning that the stake was reduced by 61.98% with the 10,000 share transaction.

Wesley Norman H who is Director at Green Mountain Coffee Roasters bought 10,000 shares at $68.25 on Nov. 26, 2013. Following this transaction, the Director owned 20,164 shares meaning that the stake was reduced by 98.39% with the 10,000 share transaction.

The shares most recently traded at $67.32, down $0.93, or 1.38% since the insider transaction. Historical insider transactions for Green Mountain Coffee Roasters go as follows:

  • 12-Week # shares bought: 3,000
  • 24-Week # shares bought: 8,000
  • 24-Week # shares sold: 10,000

The average volume for Green Mountain Coffee Roasters has been 4.4 million shares per day over the past 30 days. Green Mountain Coffee Roasters has a market cap of $10.1 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 63.55% year to date as of the close of trading on Tuesday.

Green Mountain Coffee Roasters, Inc. engages in the specialty coffee and coffeemaker businesses in the United States and Canada. The company has a P/E ratio of 21.4. Currently there are 7 analysts that rate Green Mountain Coffee Roasters a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GMCR - FREE

TheStreet Quant Ratings rates Green Mountain Coffee Roasters as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Green Mountain Coffee Roasters Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Varian Medical Systems (VAR) - FREE Research Report

Kennedy Kolleen T who is SVP and Pres. Oncology Sys. at Varian Medical Systems sold 2,972 shares at $75.49 on Nov. 26, 2013. Following this transaction, the SVP and Pres. Oncology Sys. owned 6,236 shares meaning that the stake was reduced by 32.28% with the 2,972 share transaction.

The shares most recently traded at $76.60, up $1.11, or 1.45% since the insider transaction. Historical insider transactions for Varian Medical Systems go as follows:

  • 12-Week # shares sold: 1,247
  • 24-Week # shares sold: 7,049

The average volume for Varian Medical Systems has been 771,500 shares per day over the past 30 days. Varian Medical Systems has a market cap of $8.1 billion and is part of the health care sector and health services industry. Shares are up 7.69% year to date as of the close of trading on Tuesday.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. The company has a P/E ratio of 19.0. Currently there are 7 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VAR - FREE

TheStreet Quant Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, expanding profit margins and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Varian Medical Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Jones Lang LaSalle (JLL) - FREE Research Report

Staubach Roger T who is Executive Chairman, Americas at Jones Lang LaSalle sold 10,000 shares at $97.58 on Nov. 26, 2013. Following this transaction, the Executive Chairman, Americas owned 10,000 shares meaning that the stake was reduced by 50% with the 10,000 share transaction.

The shares most recently traded at $97.21, down $0.37, or 0.38% since the insider transaction. Historical insider transactions for Jones Lang LaSalle go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 3,500
  • 24-Week # shares sold: 12,000

The average volume for Jones Lang LaSalle has been 364,200 shares per day over the past 30 days. Jones Lang LaSalle has a market cap of $4.4 billion and is part of the financial sector and real estate industry. Shares are up 16.98% year to date as of the close of trading on Tuesday.

Jones Lang LaSalle Incorporated, a financial and professional services firm, provides integrated real estate and investment management services to owner, occupier, investor, developer clients worldwide. The stock currently has a dividend yield of 0.45%. The company has a P/E ratio of 19.3. Currently there are 2 analysts that rate Jones Lang LaSalle a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JLL - FREE

TheStreet Quant Ratings rates Jones Lang LaSalle as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, attractive valuation levels and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Jones Lang LaSalle Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Harman International Industries (HAR) - FREE Research Report

Einsmann Harald who is Director at Harman International Industries sold 2,143 shares at $81.00 on Nov. 26, 2013. Following this transaction, the Director owned 21,035 shares meaning that the stake was reduced by 9.25% with the 2,143 share transaction.

The shares most recently traded at $80.52, down $0.48, or 0.6% since the insider transaction. Historical insider transactions for Harman International Industries go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 115,953
  • 24-Week # shares sold: 156,951

The average volume for Harman International Industries has been 678,300 shares per day over the past 30 days. Harman International Industries has a market cap of $5.4 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 81.56% year to date as of the close of trading on Tuesday.

Harman International Industries, Incorporated designs, develops, manufactures, and markets audio products, lighting solutions, and electronic systems, as well as digitally integrated audio and infotainment systems for the automotive industry worldwide. The stock currently has a dividend yield of 1.5%. The company has a P/E ratio of 42.0. Currently there are 2 analysts that rate Harman International Industries a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAR - FREE

TheStreet Quant Ratings rates Harman International Industries as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Harman International Industries Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Stocks Tumble as Trump Calls Off North Korea Summit

Stocks Tumble as Trump Calls Off North Korea Summit

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern